Chromatin Bio Awarded Scottish Enterprise SMART grant

October 4, 2024

Award extends company's activities in AI/ML

We are pleased to announce that Scottish Enterprise have awarded Chromatin Bio £100,000 to fund a project that aims to extend the company's platform with the introduction of a suite of AI/ML tools.


Chromatin Bio has created an integrated platform that is able to process a variety of NGS datasets and identify cell-selective and conditionally active gene regulatory elements. Then using engineering biology principles, the company can build synthetic promoters utilising these elements and create customised gene expression cassettes for its clients.


Currently the company offers this service to cell and gene therapy companies wishing to improve therapeutic construct design. Although the platform is broadly applicable across the entire biotech industry, including bio-manufacturing, industrial biotech and agriculture.


The introduction of machine learning pipelines into this process will greatly increase the efficiency of gene regulatory element discovery and improve the potency of the synthetic promoter designs, resulting in improved expression cassettes for our partners.

By Michael Roberts October 27, 2025
EDINBURGH, Scotland, Oct. 27, 2025
By Michael Roberts October 8, 2025
November 18-19, 2025 | Philadelphia PA, USA
By Michael Roberts October 1, 2025
November 3-5, 2025 | Vienna, Austria
By Michael Roberts September 1, 2025
October 6-8, 2025 | Phoenix, AZ, USA
By Michael Roberts April 14, 2025
EDINBURGH, Scotland, April 14, 2025
By Michael Roberts April 13, 2025
June 16-19, 2025 | Boston, MA, USA
By Michael Roberts April 12, 2025
May 13-17, 2025 | New Orleans, LA, USA
By Michael Roberts March 11, 2025
March 18-19, 2025 | London, UK
By Michael Roberts February 20, 2025
EDINBURGH, Scotland, Feb. 20, 2025
By Michael Roberts January 20, 2025
We are thrilled to be working with Johnson & Johnson, a leader in global healthcare innovation.